SINGAPORE (Dec 12): Singapore eDevelopment (SeD) on Monday said it is planning to diversify into the biomedical business.

SeD said in an SGX filing that it plans to diversify into the developing, researching, testing, manufacturing, licensing and distributing, and services in the area of biomedical science, biomedical healthcare and biotechnology.

The proposed diversification is subject to shareholders’ approval.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook